Anti‐TNF therapy for patients with RA can induce or worsen rheumatoid nodules, which are sometimes cavitary, during IFX, etanercept, or adalimumab treatment; however, these nodules usually improve after discontinuing biologics or switching to other biologics [12]. This evidence concerns the gene TNF and rheumatoid arthritis.